Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raydiant Oximetry
San Ramon, California, United Statesraydiantoximetry.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Raydiant Oximetry has developed two main technologies to improve maternal and fetal outcomes during childbirth. Lumerah™, a noninvasive fetal pulse oximeter, has shown improved sensitivity and specificity in preclinical trials and received FDA Breakthrough Device designation. Daisy™, a surgical device for quantifying blood loss and treating uterine atony to prevent postpartum hemorrhage after C-section, began its first clinical study enrollment in May 2024. The company has raised over $26 million across several funding rounds with support from major investors focused on women's health.
- Therapeutic areas
- Women's Health
- Modalities
- Device (for both Lumerah™ and Daisy™)Noninvasive sensor technology (Lumerah™)Surgical device (Daisy™)
- Industry
- Physiological Monitoring
02
Partnerships
GE HealthCare (joint development initiative to enhance fetal monitoring capabilities)March of Dimes Innovation FundBill & Melinda Gates Foundation grant recipientTyndall National Institute collaboration for R&D
Beyond the preview
Go deeper on Raydiant Oximetry.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Raydiant Oximetry.